Insys Therapeutics, Inc. Litigation Settlement, Expense
Insys Therapeutics, Inc. reported Litigation Settlement, Expense of $73.86 million for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LitigationSettlementExpense · last filed 2019-05-13
- Insys Therapeutics, Inc. litigation settlement, expense for the quarter ending 2019-03-31 was $73.86M, a 9881.49% increase year-over-year.
- Insys Therapeutics, Inc. litigation settlement, expense for the quarter ending 2018-12-31 was $16.01M, a 265.12% increase year-over-year.
- Insys Therapeutics, Inc. litigation settlement, expense for the quarter ending 2018-09-30 was $30.00K, a 99.98% decline year-over-year.
- Insys Therapeutics, Inc. litigation settlement, expense for the quarter ending 2018-06-30 was $0.00, a 100.00% decline year-over-year.
- Insys Therapeutics, Inc. litigation settlement, expense for fiscal 2018 was $16.78M, a 89.49% decline from fiscal 2017.
- Insys Therapeutics, Inc. litigation settlement, expense for fiscal 2017 was $159.68M, a 3994.46% increase from fiscal 2016.
- Insys Therapeutics, Inc. litigation settlement, expense for fiscal 2016 was $3.90M, a 63.26% decline from fiscal 2015.
- Insys Therapeutics, Inc. litigation settlement, expense for fiscal 2015 was $10.62M.
| Period end | Litigation Settlement, Expense 3 month | Litigation Settlement, Expense 6 month | Litigation Settlement, Expense 9 month | Litigation Settlement, Expense 9 month as first filed | Litigation Settlement, Expense 12 month | Litigation Settlement, Expense 12 month as first filed |
|---|---|---|---|---|---|---|
| 2019-03-31 | $73.86M 10-Q · filed 2019-05-13 | $89.87M derived: sum of 2 quarters · filed 2019-05-13 | $89.90M derived: sum of 3 quarters · filed 2019-05-13 | $89.90M derived: sum of 4 quarters · filed 2019-05-13 | ||
| 2018-12-31 | $16.01M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | $16.04M derived: sum of 2 quarters · filed 2019-03-13 | $16.04M derived: sum of 3 quarters · filed 2019-03-13 | $16.78M 10-K · filed 2019-03-13 | ||
| 2018-09-30 | $30.00K 10-Q · filed 2018-11-09 | $30.00K derived: sum of 2 quarters · filed 2018-11-09 | $770.00K 10-Q · filed 2018-11-09 | $5.15M derived: sum of 4 quarters · filed 2019-05-13 | ||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $740.00K 10-Q · filed 2018-08-09 | $5.12M derived: sum of 3 quarters · filed 2019-05-13 | $155.97M derived: sum of 4 quarters · filed 2019-05-13 | ||
| 2018-03-31 | $740.00K 10-Q · filed 2019-05-13 | $5.12M derived: sum of 2 quarters · filed 2019-05-13 | $155.97M derived: sum of 3 quarters · filed 2019-05-13 | $160.42M derived: sum of 4 quarters · filed 2019-05-13 | ||
| 2017-12-31 | $4.38M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | $155.23M derived: sum of 2 quarters · filed 2019-03-13 | $159.68M derived: sum of 3 quarters · filed 2019-03-13 | $159.68M 10-K · filed 2019-03-13 | ||
| 2017-09-30 | $150.85M 10-Q · filed 2018-11-09 | $155.30M derived: sum of 2 quarters · filed 2018-11-09 | $155.30M 10-Q · filed 2018-11-09 | |||
| 2017-06-30 | $4.45M 10-Q · filed 2018-08-09 | $4.45M 10-Q · filed 2018-08-09 | ||||
| 2016-12-31 | $3.90M 10-K · filed 2018-03-12 | $3.90M 10-K · filed 2019-03-13 | ||||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q/A 9 month · filed 2018-03-12 | $312.00K derived: sum of 2 quarters · filed 2018-03-12 | $2.62M derived: sum of 3 quarters · filed 2018-03-12 | $10.62M 10-K · filed 2018-03-12 | $9.52M 10-K · filed 2016-02-29 | |
| 2015-09-30 | -$789.00K 10-Q · filed 2016-11-03 | $2.62M derived: sum of 2 quarters · filed 2017-04-07 | $10.62M 10-Q/A · filed 2017-04-07 | $9.52M 10-Q · filed 2015-11-05 | ||
| 2015-06-30 | $2.30M 10-Q/A · filed 2017-04-07 | $10.30M 10-Q/A · filed 2017-04-07 | ||||
| 2015-03-31 | $8.00M 10-Q/A · filed 2017-04-07 |